Biomarin Pharmaceutical reported $505.34M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US USD 130.71M 3.85M
Acorda Therapeutics ACOR:US USD 33.01M 1.96M
Agios Pharmaceuticals AGIO:US USD 3.52M 2.07M
Alnylam Pharmaceuticals ALNY:US USD 264.31M 39.49M
Amgen AMGN:US USD 6.65B 58M
Bayer BAYN:GR EUR 11.28B 1.54B
Biogen BIIB:US USD 2.51B 80.6M
Biomarin Pharmaceutical BMRN:US USD 505.34M 28.45M
Bluebird Bio BLUE:US USD 71K 1.45M
Gilead Sciences GILD:US USD 7.04B 782M
Insmed INSM:US USD 67.73M 2.51M
Intercept Pharmaceuticals ICPT:US USD 77.59M 5.83M
IONIS PHARMACEUT IONS:US USD 159.77M 25.98M
Moderna Inc MRNA:US USD 3.36B 1.38B
Neurocrine Biosciences NBIX:US USD 387.9M 9.7M
Ptc Therapeutics PTCT:US USD 217.13M 51.6M
Puma Biotechnology PBYI:US USD 57.1M 2.42M
Regeneron Pharmaceuticals REGN:US USD 2.94B 79M
Roche Holding ROG:VX CHF 32.3B 207M
Sangamo Biosciences SGMO:US USD 26.46M 2.92M
Sarepta Therapeutics SRPT:US USD 230.27M 3.22M
Seattle Genetics SGEN:US USD 510.3M 12.8M
Ultragenyx Pharmaceutical RARE:US USD 90.7M 1.36M
United Therapeutics UTHR:US USD 516M 49.1M
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M
YTE INCY:US USD 823.3M 88.09M